Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

24 results
Display

Annual Eradication Rates of Helicobacter pylori Infection over 9 Years in Incheon

Kim BG, Kim JS, Kim BW, Ji JS, Choi H, Park SM

BACKGROUND/AIMS: Failure of Helicobacter pylori eradication has increased over the past decade and is related to increased antibiotic resistance. The aim of this study was to estimate the eradication rates...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Trend in the Eradication Rates of Helicobacter pylori Infection in the Last 8 Years in Daegu: A Single Center Experience

Kim SH, Jung JT, Kwon JG, Kim EY, Kang SM, Song JE

BACKGROUND/AIMS: Helicobacter pylori eradication rates achieved by first-line triple treatment with proton pump inhibitor (PPI), clarithromycin, and amoxicillin have decreased to 70~85%, in part due to increasing antimicrobial resistance. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changes in the Eradication Rate of Conventional Triple Therapy for Helicobacter pylori Infection in Korea

Heo J, Jeon SW

Although, the prevalence of Helicobacter pylori infection in Korea has declined owing to the eradication therapy, recent seroprevalence of H. pylori infection is still reported to be as high as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
First-line Helicobacter pylori Eradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study

Lee MW, Kim GH, Han SY, Park YJ, Jeon HK, Lee BE, Song GA

BACKGROUND/AIMS: The eradication rate of Helicobacter pylori with standard triple therapy as a first-line treatment has decreased to 70~85%. Recently, concomitant therapy has been reported to overcome this decrease in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Trend in the Eradication Rates of Helicobacter pylori Infection Over the Last 10 Years in West Gyeonggi-do, Korea: A Single Center Experience

Park JS, Park JE, Oh BS, Yoon BW, Kim HK, Lee JW, Kim NH, Cho WS, Woo YS, Jahng J, Kim YS

BACKGROUND/AIMS: The eradication rate of Helicobacter pylori (H. pylori) has been decreasing recently in Korea due to antibiotics resistance. The aim of this study was to investigate the trend of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura

Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N

BACKGROUND/AIMS: The aim of this study was to evaluate the ability of Helicobacter pylori eradication treatment to increase platelet counts in Korean patients with chronic idiopathic thrombocytopenic purpura (ITP). METHODS: A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does Standard Triple Therapy Still Have a Role in First-Line Helicobacter pylori Eradication in Korea?

Jeon HK, Kim GH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Decreased Eradication Rates of Helicobacter pylori and Problem Solving

Jo Y

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy

Kim SE, Roh JH, Park MI, Park SJ, Moon W, Kim JH, Jung K, Heo JJ

BACKGROUND/AIMS: Both bismuth-containing quadruple therapy and moxifloxacin-containing triple therapy have been suggested as second-line eradication therapy for Helicobacter pylori (H. pylori) infection. We aimed to evaluate the efficacy of 14-day...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children

Hong J, Yang HR

  • KMID: 2315346
  • Pediatr Gastroenterol Hepatol Nutr.
  • 2012 Dec;15(4):237-242.
PURPOSE: The aim of this study was to assess and compare the efficacies of proton pump inhibitor-based triple therapy and bismuth-based quadruple therapy as first-line treatments for Helicobacter pylori eradication...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Influence of Iron Deficiency on Helicobacter pylori Eradication

Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Seo KI, Lim SK, Jung JK, Kim HJ, Yeo GE, Jeon SC, Cho DS, Han YJ

BACKGROUND/AIMS: Helicobacter pylori is a distinctive pathogen that lives in the gastric mucosa and is a well known risk factor of gastric adenocarcinoma. Iron deficiency aggravates the development of H....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Future Trends of Helicobacter pylori Eradication Therapy in Korea

Lee JY, Kim N

The prevalence of Helicobacter pylori infection in Korea shows a decreasing trend and has changed to that of developed country, especially for those below 30 years old. However, the primary...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Roadmap for elimination of gastric cancer in Korea

Graham DY

Most gastric cancers are caused by infection with the common human bacterial pathogen, Helicobacter pylori. It is now accepted that gastric cancer can be prevented and virtually eliminated by H....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Therapeutic Strategies against Helicobacter pylori

Kang BK, Park SM, Kim BW

The standard therapy for Helicobacter pylori infection in Korea is a triple-drug regimen consisting of a proton pump inhibitor with two antibiotics such as clarithromycin, amoxicillin, and metronidazole. However, as...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Trends in the Eradication Rates of Helicobacter pylori Infection in Daegu and Gyeongsangbuk-do, Korea: Multicenter Study over 13 Years

Jung YS, Lee SH, Park CS, Oh MJ, Kim KO, Jang BI, Jeon SW, Jung MK, Park KS, Kim ES, Cho KB, Jung JT, Kwon JG, Kim EY, Kim WJ, Yang CH

BACKGROUND/AIMS: The eradication rates of Helicobacter pylori infection have been reported to have decreased over the years due to antibiotics resistance. The aim of this study is to investigate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Meta-Analysis of First-Line Triple Therapy for Helicobacter pylori Eradication in Korea: Is It Time to Change?

Gong EJ, Yun SC, Jung HY, Lim H, Choi KS, Ahn JY, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Kim JH

Proton pump inhibitor (PPI)-based triple therapy consisting of PPI, amoxicillin, and clarithromycin, is the recommended first-line treatment for Helicobacter pylori infection. However, the eradication rate of triple therapy has declined...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Guidelines for Helicobacter pylori Treatment: Comparisons between Korea and Japan

Lee SY

Korea and Japan show the highest incidence of gastric cancer and Helicobacter pylori infection. New 2013 guidelines on H. pylori infection differ between the two countries with regard to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Association between Helicobacter pylori Infection and Body Weight among Children

Choi JS, Ko KO, Lim JW, Cheon EJ, Lee GM, Yoon JM

PURPOSE: We performed to reveal the association between the Helicobacter pylori infection and body weight among children. METHODS: Out retrospective study included patients who underwent the H. pylori immunoglobulin G testing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Hip Fusion in Living Activity

Cha SI, Lee HK, Lee SH, Kang SY

Hip fusion has provided disease eradication, stabilization, pain relief and strenuous activity, but the possible complication of pseudarthrosis as well as loss of all motion is a drawback. Total hip...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mass vaccination has led to the elimination of rabies since 2014 in South Korea

Yang DK, Kim HH, Lee KK, Yoo JY, Seomun H, Cho IS

PURPOSE: Rabies is one of the most fatal diseases, but it is 100% preventable in animals by vaccination. In this study, we present the epidemiological features of, and national preventive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr